Dept. of Biotechnology hosted a CME program ‘Cracking the Code: Lessons from Developing Next-Gen Therapies’ on June 11th, 2026. Guest speaker Dr. Venkataraman Sriram (Foundery Biosciences) discussed therapeutic target validation and the impact of immunology on drug discovery, with a focus on the IL-10 signaling pathway.
